Related Experiment Video
Updated: Dec 25, 2025

Analysis of Cell Cycle Position in Mammalian Cells
Published on: January 21, 2012
RYBP inhibits esophageal squamous cell carcinoma proliferation through downregulating CDC6 and CDC45 in G1-S phase
Yue Ke1, Wei Guo1, Shan Huang1
1Department of Radiation Oncology, Second Affiliated Hospital, Xi'an Jiaotong University, 710004 Xi'an, China.
Aims:
RING1 and YY1-binding protein (RYBP) is an epigenetic regulator and plays crucial roles in embryonic development. The anti-tumor effect of RYBP has been reported in several cancers recently, but the role of RYBP in esophageal squamous cell carcinoma (ESCC) has not been fully elucidated. The present study aimed to investigate the biological function and the underlying molecular mechanisms of RYBP in ESCC.
Materials And Methods:
We detected the expression of RYBP in ESCC tissue microarrays (TMA) by immunohistochemistry. Cell proliferation was assessed by CCK8 and colony formation assays. Cell cycle was analyzed by flow cytometry. Gene expression was determined by transcriptome arrays, quantitative real-time PCR (qRT-PCR) and Western blot. Four-week-old male nude mice were used to evaluate the effect of RYBP in ESCC growth.
Key Findings:
We found that RYBP was downregulated in ESCC compared with adjacent normal tissues. A high level of RYBP expression predicted a better outcome of ESCC patients. Furthermore, overexpression of RYBP inhibited ESCC growth both in vitro and in vivo. Transcriptome arrays and functional studies showed that RYBP decreased the expression of genes related to cell cycles, especially CDC6 and CDC45, which were essential to initiate the DNA replication and G1-S transition.
Significance:
Taken together, our study suggests that RYBP suppresses ESCC proliferation by downregulating CDC6 and CDC45, thus inhibiting the G1-S transition.
Insights
RING1 and YY1-binding protein (RYBP) suppresses esophageal squamous cell carcinoma (ESCC) growth by downregulating cell cycle genes CDC6 and CDC45. This epigenetic regulator
Area of Science:
- Epigenetics
- Cancer Biology
- Molecular Oncology
Background:
- RING1 and YY1-binding protein (RYBP) is an epigenetic regulator with known roles in embryonic development.
- RYBP's anti-tumor effects have been observed in various cancers, but its specific role in esophageal squamous cell carcinoma (ESCC) remains unclear.
Purpose of the Study:
- To investigate the biological function of RYBP in ESCC.
- To elucidate the molecular mechanisms underlying RYBP's role in ESCC progression.
Main Methods:
- Immunohistochemistry on ESCC tissue microarrays to assess RYBP expression.
- In vitro assays (CCK8, colony formation, flow cytometry) to evaluate cell proliferation and cell cycle.
- Transcriptome arrays, qRT-PCR, and Western blot to analyze gene expression.
- In vivo studies using nude mice to assess RYBP's effect on tumor growth.
Main Results:
- RYBP expression was found to be downregulated in ESCC tissues compared to normal adjacent tissues.
- Higher RYBP expression correlated with better patient outcomes in ESCC.
- Overexpression of RYBP inhibited ESCC cell proliferation and tumor growth both in vitro and in vivo.
- RYBP was shown to decrease the expression of cell cycle-related genes, specifically CDC6 and CDC45, which are critical for DNA replication and G1-S phase transition.
Conclusions:
- RYBP acts as a tumor suppressor in ESCC.
- RYBP inhibits ESCC proliferation by downregulating CDC6 and CDC45, thereby impeding the G1-S cell cycle transition.
Related Concept Videos
Negative Regulator Molecules
Inhibition of Cdk Activity
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
The Ras Gene
Ras is a...
Mitogens and the Cell Cycle

